Skip to main content

Table 1 Comparisons of the enrolment characteristics of the analysis cohort by creatinine clearance and estimated glomerular filtration rate categories

From: Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected kenyan adults not initially requiring combination antiretroviral therapy

  

Creatinine clearance (mL/min)a Glomerular filtration rateb (mL/min/1.73 m2)b

Characteristic c

Total

(n = 7383)

≥60

(n = 5890; 79.8%)

< 60

(n = 1493; 20.2%)

P

value

≥60

(n = 6689;

90.6%)

< 60

(n = 694;

9.4%)

P

value

Age, years

35.5

34.3

41.8

< 0.001

35.1

39.0

< 0.001

 

(29.3-44.0)

(28.7-41.0)

(33.8-49.4)

 

(29.1-42.6)

(32.1-46.5)

 

Female, n (%)

5399 (73.1)

4289 (72.8)

1110 (74.4)

0.24

4851 (72.5)

548 (79.0)

< 0.001

CD4 cell count/mm3, n (%)

       

   >500

2263 (30.7)

1906 (32.4)

357 (23.9)

< 0.001

2075 (31.0)

188 (27.1)

0.005

   350-500

1993 (27.0)

1605 (27.2)

388 (26.0)

 

1821 (27.2)

172 (24.8)

 

   < 350

3127 (42.4)

2379 (40.4)

748 (50.1)

 

2793 (41.8)

334 (48.1)

 

WHO stage 1, n (%)

5019 (68.0)

4054 (68.8)

965 (64.6)

0.002

4528 (67.7)

491 (70.8)

0.10

Haemoglobin, g/dL

12.6

12.6

12.2

< 0.001

12.6

12.3

0.003

 

(10.9-14.0)

(11.0-14.0)

(10.6-13.7)

 

(11.0-14.0)

(10.6-13.8)

 

Weight, kg

59.0

60.0

53.4

< 0.001

59.0

59.8

0.04

 

(52.0-65.5)

(54.0-67.0)

(48.0-60.0)

 

(52.0-65.5)

(53.0-67.0)

 

Serum creatinine, mg/dL

0.8

0.77

1.1

< 0.001

0.80

1.4

< 0.001

 

(0.7-1.0)

(0.66-0.90)

(1.0-1.3)

 

(0.68-0.93)

(1.2-1.6)